Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12069)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2015 (publication date) through Jul 22, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vespasiani-Gentilucci U, Galati G, Gallo P, De Vincentis A, Riva E, Picardi A. Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens. World J Gastroenterol 2015; 21(24): 7412-7426 [PMID: 26139987 DOI: 10.3748/wjg.v21.i24.7412] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i24/7412.htm |
| Number | Citing Articles |
| 1 |
Nawfal R Hussein. Sustained Virological Response After Six Weeks Treatment with a Sofosbuvir-Containing Regimen in a Patient Infected with Hepatitis C Virus Genotype 4: A Case Report. International Journal of Infection 2016; 4(3) doi: 10.5812/iji.41216
|
| 2 |
Rafael Gonzalez Alonso, Maria Fernanda Gomez, Mary Alice O’Dowd. Geriatric Gastroenterology. 2020; : 1 doi: 10.1007/978-3-319-90761-1_92-1
|
| 3 |
Georg Dultz, Tobias Müller, Jörg Petersen, Stefan Mauss, Tim Zimmermann, Marion Muche, Karl-Georg Simon, Thomas Berg, Stefan Zeuzem, Dietrich Hüppe, Klaus Böker, Heiner Wedemeyer, Tania M. Welzel, Rainer Günther, Holger Hinrichsen, Renate Heyne, Johannes Roth, Tobias Goeser, Rainer Ullrich, Christine John, Wolf Peter Hofmann, Gerlinde Teuber, Hjördis Möller, Axel Baumgarten, Jeannette Schwenzer, Anita Pathil, Michael R. Kraus, Andreas Weber, Maria-Christina Jung, Guido Gerken, Christoph Antoni, Margareta Frank Doss, Andreas Schober, Martin Hoffstadt, Armand v. Lucadou, Hermann Steffens, Hartwig Klinker, Andreas Geier, Gerd Klausen, Peter Buggisch, Markus Cornberg, Christoph Sarrazin, Michael P. Manns, Claus Niederau, Ulla Protzer, Peter Schirmacher. Effectiveness and Safety of Direct-Acting Antiviral Combination Therapies for Treatment of Hepatitis C Virus in Elderly Patients: Results from the German Hepatitis C Registry. Drugs & Aging 2018; 35(9): 843 doi: 10.1007/s40266-018-0572-0
|
| 4 |
Adriano De Santis, Daniela Maggi, Federica Lubrano Lobianco. Safety and efficacy of directly‐acting antiviral therapy for chronic hepatitis C virus in elderly people. AGING MEDICINE 2021; 4(4): 304 doi: 10.1002/agm2.12190
|
| 5 |
Alessandro Federico, Giuseppe Gerardo Caprio, Anna Maria Dalise, Michelangela Barbieri, Marcello Dallio, Carmelina Loguercio, Giuseppe Paolisso, Maria Rosaria Rizzo. Cirrhosis and frailty assessment in elderly patients. Medicine 2020; 99(2): e18501 doi: 10.1097/MD.0000000000018501
|
| 6 |
Vincent Soriano, Pablo Labarga, Carmen de Mendoza, José V Fernández-Montero, Isabella Esposito, Laura Benítez-Gutiérrez, José M Peña, Pablo Barreiro. New hepatitis C therapies for special patient populations. Expert Opinion on Pharmacotherapy 2016; 17(2): 217 doi: 10.1517/14656566.2016.1112790
|
| 7 |
Tamer Elbaz, Mahmoud Abdo, Heba Omar, Essam A. Hassan, Amr M. Zaghloul, Mohamed Abdel‐Samiee, Ahmed Moustafa, Abdallah Qawzae, Mostafa Gamil, Gamal Esmat. Efficacy and safety of sofosbuvir and daclatasvir with or without ribavirin in elderly patients with chronic hepatitis C virus infection. Journal of Medical Virology 2019; 91(2): 272 doi: 10.1002/jmv.25287
|
| 8 |
Stephanie E Perrett, Amy Plimmer, Ananda Giri Shankar, Noel Craine. Prevalence of HCV in prisons in Wales, UK and the impact of moving to opt-out HCV testing. Journal of Public Health 2020; 42(2): 423 doi: 10.1093/pubmed/fdaa022
|
| 9 |
Jong Eun Yeon. Treatment of Chronic Hepatitis C in Older Adults. Korean Journal of Clinical Geriatrics 2023; 24(3): 93 doi: 10.15656/kjcg.2023.24.3.93
|
| 10 |
Antonio De Vincentis, Luisa Costanzo, Umberto Vespasiani-Gentilucci, Antonio Picardi, Stefania Bandinelli, Luigi Ferrucci, Raffaele Antonelli Incalzi, Claudio Pedone. Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people. Digestive and Liver Disease 2019; 51(9): 1330 doi: 10.1016/j.dld.2019.01.017
|
| 11 |
Chiara Mazzarelli, Aisling Considine, Kate Childs, Ivana Carey, Matteo Angelo Manini, Abid Suddle, Geoffrey Dusheiko, Kosh Agarwal, Mary D. Cannon. Efficacy and Tolerability of Direct‐Acting Antivirals for Hepatitis C in Older Adults. Journal of the American Geriatrics Society 2018; 66(7): 1339 doi: 10.1111/jgs.15392
|
| 12 |
Jieun Lee, Sang Bong Ahn, Sun Young Yim, Jihyun An, Dae Won Jun, Min Jung Ko, Dong Ah Park, Jeong‐Ju Yoo. Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis. Journal of Viral Hepatitis 2022; 29(7): 496 doi: 10.1111/jvh.13679
|
| 13 |
J. Vermehren, K.‐H. Peiffer, C. Welsch, G. Grammatikos, M.‐W. Welker, N. Weiler, S. Zeuzem, T. M. Welzel, C. Sarrazin. The efficacy and safety of direct acting antiviral treatment and clinical significance of drug–drug interactions in elderly patients with chronic hepatitis C virus infection. Alimentary Pharmacology & Therapeutics 2016; 44(8): 856 doi: 10.1111/apt.13769
|
| 14 |
Daniel Esteban Pino Marín, Pedro Amariles, Jaime Alberto Peláez Alvárez, Gloria Priscilla Alvárez Osorio, Juliana González Ceballos. Aproximación para establecer y evaluar la relevancia clínica de las interacciones medicamentosas en el tratamiento de pacientes infectados con virus de hepatitis C, revisión estructurada (actualización 2015 – 2017). Revista Colombiana de Gastroenterología 2019; 34(2): 159 doi: 10.22516/25007440.252
|
| 15 |
Claudia Fabrizio, Annalisa Saracino, Luigia Scudeller, Eugenio Milano, Raffaele Dell’Acqua, Giuseppe Bruno, Sergio Lo Caputo, Laura Monno, Michele Milella, Gioacchino Angarano. The elderly and direct antiviral agents: Constraint or challenge?. Digestive and Liver Disease 2017; 49(9): 1036 doi: 10.1016/j.dld.2017.05.019
|
| 16 |
Michał BRZDĘK, Dorota ZARĘBSKA-MICHALUK, Krzysztof TOMASIEWICZ, Magdalena TUDRUJEK-ZDUNEK, Beata LORENC, Włodzimierz MAZUR, Hanna BERAK, Justyna JANOCHA-LITWIN, Jakub KLAPACZYŃSKI, Marek SITKO, Ewa JANCZEWSKA, Dorota DYBOWSKA, Anna PARFIENIUK-KOWERDA, Anna PIEKARSKA, Jerzy JAROSZEWICZ, Robert FLISIAK. Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly people. Minerva Medica 2024; 115(3) doi: 10.23736/S0026-4806.24.09238-3
|
| 17 |
Nawfal R Hussein. Sofosbuvir and Ribavirin to Treat Hepatitis C Virus Genotype 4 Infection in a 65-Year-Old Patient With Diabetes and Low Platelet: A Case Report. International Journal of Infection 2016; 3(4) doi: 10.17795/iji-36642
|
| 18 |
Chung-Feng Huang, Ming-Lung Yu. Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developments. Expert Opinion on Pharmacotherapy 2017; 18(17): 1867 doi: 10.1080/14656566.2017.1400010
|
| 19 |
Nawfal R Hussein. Sustained Virological Response After Six Weeks Treatment with a Sofosbuvir-Containing Regimen in a Patient Infected with Hepatitis C Virus Genotype 4: A Case Report. International Journal of Infection 2016; (Inpress) doi: 10.17795/iji-41216
|
| 20 |
Daniel J. Ruzicka, Jumpei Tetsuka, Go Fujimoto, Tatsuya Kanto. Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3148-z
|
| 21 |
Rafael Gonzalez Alonso, Maria Fernanda Gomez, Mary Alice O’Dowd. Geriatric Gastroenterology. 2021; : 2313 doi: 10.1007/978-3-030-30192-7_92
|
| 22 |
Ugo Fedeli, Elena Schievano. Mortality Waves Related to Hepatitis C Virus Infection: Multiple Causes of Death Data From the United States and Northern Italy Compared. Clinical Infectious Diseases 2016; 63(6): 849 doi: 10.1093/cid/ciw421
|
| 23 |
Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, Tsai-Yuan Hsieh, Yi-Hsiang Huang, Wei-Wen Su, Pin-Nan Cheng, Chih-Lin Lin, Ching-Chu Lo, Chi-Yi Chen, Jyh-Jou Chen, Qian Ma, Craig Brooks-Rooney, Jia-Horng Kao. Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study. Journal of the Formosan Medical Association 2019; 118(6): 1014 doi: 10.1016/j.jfma.2018.10.020
|
| 24 |
F. Giudici, B. Bertisch, F. Negro, G. Stirnimann, B. Müllhaupt, D. Moradpour, A. Cerny, O. Keiser. Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person‐centred approach. Journal of Viral Hepatitis 2016; 23(9): 697 doi: 10.1111/jvh.12535
|
| 25 |
Alexandre Pariente, Jean-Pierre Arpurt, Andre-Jean Remy, Isabelle Rosa-Hezode, Xavier Causse, Frederic Heluwaert, Gilles Macaigne, Jean Henrion, Christophe Renou, Matthieu Schnee, Hatem Salloum, Severine Hommel, Christophe Pilette, Ramuntxo Arotcarena, Georges Barjonet, Hortensia Lison, Frangois Bourhis, Vincent Jouannaud, Arnaud Pauwels, Yann Le-Bricquir, Edmond Geagea, Bertrand Condat, Marie-Pierre Ripault, David Zanditenas, Stephanie de Montigny-Lenhardt, Helene Labadie, Bertrand Tissot, Eric Maringe, Jean-Frangois Cadranel, Herve Hagege, Bruno Lesgourgues. Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals. Annals of Hepatology 2019; 18(1): 193 doi: 10.5604/01.3001.0012.7912
|
| 26 |
Ugo Fedeli, Enrico Grande, Francesco Grippo, Luisa Frova. Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data. World Journal of Gastroenterology 2017; 23(10): 1866-1871 doi: 10.3748/wjg.v23.i10.1866
|
| 27 |
|